Clinical significance of the T(-344)C polymorphism of the aldosterone synthase gene (CYP11B2) in the prognosis of cardiorenal syndrome in diabetes mellitus
Open Access
- 3 January 2023
- journal article
- research article
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 19 (4) , 48-55
Abstract
Objective. To evaluate the role of the T(-344)C polymorphism of CYP11B2 gene in the development of cardiorenal syndrome (CRS) in diabetes mellitus (DM).Materials and methods. 270 patients with type 1 and type 2 diabetes aged over 25 years were examined. All patients underwent molecular genetic analysis using deoxyribonucleic acid isolated from whole venous blood.Results. The TT genotype was associated with the risk of developing CRS manifestations such as left ventricular hypertrophy (odds ratio (OR) 2.64; 95% CI (0.93–4.19), chronic heart failure (OR 4.26; 95% CI (2.26 - 8.06), subclinical atherosclerosis (OR 4.04; 95% CI (1.89 - 8.58), chronic kidney disease (CKD) (OR 10.77; 95% CI (3.56 - 32.61), and the CT genotype (OR 3.28; 95% CI (1.02 – 10.59) with CKD risk..Conclusion. There are pathogenetic associations between renin-angiotensin-aldosterone system, cardiovascular complications and a decrease of renal function. Further research is needed for a deep understanding of the complex pathogenetic mechanisms of the development and progression of cardiovascular and renal pathology.Keywords
This publication has 20 references indexed in Scilit:
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- Association of the −344T/C polymorphism in aldosterone synthase gene promoter with left ventricular structure in Chinese Han: A meta-analysisClinical and Experimental Hypertension, 2017
- Physiology and pathophysiology of the plasminogen system in the kidneyPflügers Archiv - European Journal of Physiology, 2017
- Up-regulation of FGF23 release by aldosteroneBiochemical and Biophysical Research Communications, 2016
- Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based StudyJournal of Investigative Medicine, 2015
- Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2014
- A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD ModelPLOS ONE, 2012
- Association of Aldosterone and Cortisol with Cardiovascular Risk Factors in Prehypertension StageInternational Journal of Hypertension, 2012
- Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF- B pathwayRheumatology, 2007
- Plasma Reduced Homocysteine and Other Aminothiol Concentrations in Patients With CKDAmerican Journal of Kidney Diseases, 2006